| Regulation of cellular Cyclin D1 gene by arsenic is mediated through miR-2909 M Sharma, S Sharma, M Arora, D Kaul Gene 522 (1), 60-64, 2013 | 49 | 2013 |
| Emerging role of precision medicine in biliary tract cancers JM Bogenberger, TT DeLeon, M Arora, DH Ahn, MJ Borad NPJ precision oncology 2 (1), 21, 2018 | 29 | 2018 |
| Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma TT DeLeon, DH Ahn, JM Bogenberger, PZ Anastasiadis, M Arora, ... Future Oncology 14 (6), 553-566, 2018 | 27 | 2018 |
| Evaluation of NUC-1031: a first-in-class ProTide in biliary tract cancer M Arora, JM Bogenberger, A Abdelrahman, JL Leiting, X Chen, JB Egan, ... Cancer chemotherapy and pharmacology 85, 1063-1078, 2020 | 17 | 2020 |
| Oncogenic nature of a novel mutant AATF and its interactome existing within human cancer cells S Sharma, D Kaul, M Arora, D Malik Cell biology international 39 (3), 326-333, 2015 | 17 | 2015 |
| MALT1 induced immune response is governed by miR-2909 RNomics D Kaul, M Arora, A Garg, S Sharma Molecular immunology 64 (1), 210-217, 2015 | 16 | 2015 |
| Arsenic programmes cellular genomic-immunity through miR-2909 RNomics D Kaul, S Sharma, M Sharma, M Arora, M Arora Gene 536 (2), 326-331, 2014 | 15 | 2014 |
| Cellular proteolytic modification of tumor-suppressor CYLD is critical for the initiation of human T-cell acute lymphoblastic leukemia M Arora, D Kaul, N Varma, RK Marwaha Blood Cells, Molecules, and Diseases 54 (1), 132-138, 2015 | 12 | 2015 |
| Cell-Free Tumor DNA Dominant Clone Allele Frequency Is Associated With Poor Outcomes in Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy PLS Uson Junior, U Majeed, J Yin, G Botrus, MB Sonbol, DH Ahn, ... JCO Precision Oncology 6 (1), e2100274, 2022 | 11 | 2022 |
| Oncolytic Virus with Attributes of Vesicular Stomatitis Virus and Measles Virus in Hepatobiliary and Pancreatic Cancers BM Nagalo, CA Breton, Y Zhou, M Arora, JM Bogenberger, O Barro, ... Molecular Therapy-Oncolytics 18, 546-555, 2020 | 11 | 2020 |
| Oncolytic virotherapy in upper gastrointestinal tract cancers R Yokoda, BM Nagalo, M Arora, JB Egan, JM Bogenberger, TT DeLeon, ... Oncolytic Virotherapy, 13-24, 2018 | 11 | 2018 |
| FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations PLS Uson Junior, TT DeLeon, JM Bogenberger, RK Pai, HE Kosiorek, ... Digestive diseases and sciences, 1-9, 2022 | 6 | 2022 |
| Synergistic combination of cytotoxic chemotherapy and cyclin‐dependent kinase 4/6 inhibitors in biliary tract cancers M Arora, JM Bogenberger, AM Abdelrahman, J Yonkus, R Alva‐Ruiz, ... Hepatology 75 (1), 43-58, 2022 | 6 | 2022 |
| Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers BM Nagalo, Y Zhou, EJ Loeuillard, C Dumbauld, O Barro, NM Elliott, ... Hepatology, 2022 | 5 | 2022 |
| Functional nature of a novel mutant CYLD observed in pediatric lymphoblastic B‐cell leukemia M Arora, D Kaul, N Varma Pediatric blood & cancer 62 (6), 1066-1069, 2015 | 5 | 2015 |
| Recent advances in understanding cholangiocarcinoma PLSU Junior, M Arora, JM Bogenberger, MJ Borad Faculty Reviews 9, 2020 | 1 | 2020 |
| FGFR2-IIIb Expression by Immunohistochemistry Has High Specificity in Cholangiocarcinoma with FGFR2 Genomic Alterations. TT DeLeon, JM Bogenberger, RK Pai, HE Kosiorek, J Yin, DH Ahn, ... Digestive Diseases and Sciences, 2021 | | 2021 |
| Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy U Majeed, G Botrus, MB Sonbol, D Ahn, J Starr, J Jones, H Babiker, ... | | 2021 |
| Cell-Free Tumor DNA Dominant Clone Allele Frequency (DCAF) Is Associated With Poor Outcomes In Advanced Biliary Cancers Treated With Platinum-Based Chemotherapy PLSU Junior, U Majeed, G Botrus, MB Sonbol, D Ahn, J Starr, J Jones, ... medRxiv, 2021 | | 2021 |
| Synergy of cyclin dependentkinase 4/6 inhibitors with cytotoxic chemotherapy in cholangiocarcinoma M Arora, J Bogenberger, N Bolni, Y Zhou, L Kannan, J Egan, R Yokoda, ... Cancer Research 79 (13_Supplement), 4417-4417, 2019 | | 2019 |
James M. BogenbergerAssistant Professor, Mayo ClinicVerified email at mayo.edu
